KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Capital Expenditures (2016 - 2025)

Globus Medical's Capital Expenditures history spans 15 years, with the latest figure at -$69.2 million for Q3 2025.

  • For Q3 2025, Capital Expenditures fell 34.22% year-over-year to -$69.2 million; the TTM value through Dec 2025 reached $13.5 million, down 88.34%, while the annual FY2025 figure was $13.5 million, 88.34% down from the prior year.
  • Capital Expenditures reached -$69.2 million in Q3 2025 per GMED's latest filing, down from $72.7 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $110.6 million in Q4 2024 to a low of -$69.2 million in Q3 2025.
  • Average Capital Expenditures over 5 years is $7.8 million, with a median of $4.1 million recorded in 2022.
  • The largest YoY upside for Capital Expenditures was 9698.67% in 2024 against a maximum downside of 8622.98% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at -$35.3 million in 2021, then plummeted by 36.77% to -$48.3 million in 2022, then skyrocketed by 102.34% to $1.1 million in 2023, then soared by 9698.67% to $110.6 million in 2024, then tumbled by 162.56% to -$69.2 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Capital Expenditures are -$69.2 million (Q3 2025), $72.7 million (Q2 2025), and $10.0 million (Q1 2025).